Trial intelligence / Profile preview

Effect of N-acetylcysteine on hydrogen sulfide in chronic kidney disease

2010-022994-32Phase 3Active

Sponsor
University Medical Center Utrecht
Start
Nov 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of acetylcysteine in chronic kidney disease (CKD) (3 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Primary. Started Nov 2010; status: active.

02

Drugs

acetylcysteine
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on 2010-022994-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-022994-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call